A new targeted drug treatment for small cell lung cancer, understanding how obesity drives endometrial cancer, and predicting early-stage melanoma spread are among the research topics being presented by scientists with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at the American Association for Cancer Research Annual Meeting April 25-30 in Chicago.

Researchers using next-generation DNA sequqncing have indenitified four gene mutations linked to lethal stomach cancers, potentially paving the way for more targeted, less aggressive procedures. 

Bad habits such as smoking, heavy drinking and lack of exercise must be tackled as early as possible to boost the odds of a happy and healthy old age. 

The National Foundation for Cancer Research (NFCR) congratulates Dr. Rakesh K. Jain on receiving the 2025 AACR Award for Lifetime Achievement in Cancer Research. A globally recognized leader in oncology, Dr. Jain has made pioneering contributions to understanding the tumor microenvironment and developing novel cancer treatment strategies, including the theory of vascular normalization. Supported by NFCR for over 25 years, Dr. Jain’s work has transformed cancer therapy and education, impacting patient outcomes across multiple cancer types. The award will be presented at the AACR Annual Meeting in Chicago on April 27, 2025.

Shruti Gupta, MD, MPH, and David Leaf, MD, MMSc, of the Renal Division, Department of Medicine at Brigham and Women’s Hospital are the first and senior authors, respectively, of a paper published in JAMA Oncology, “Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury: A Multicenter Cohort Study.” 

Innovative statistical method helps determine ideal threshold times in restricted mean survival time analyses